0000874015-13-000027.txt : 20130201 0000874015-13-000027.hdr.sgml : 20130201 20130201193859 ACCESSION NUMBER: 0000874015-13-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130130 FILED AS OF DATE: 20130201 DATE AS OF CHANGE: 20130201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENNETT C FRANK CENTRAL INDEX KEY: 0001073387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 13568049 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-01-30 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073387 BENNETT C FRANK C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Antisense Research Restricted Stock Units 2013-01-30 2013-01-30 4 A 0 5660 0 A Common Stock 5660 5660 D Employee Stock Option (right to buy) 14.69 2013-01-30 2013-01-30 4 A 0 34000 0 A 2014-01-02 2020-01-29 Common Stock 34000 34000 D Each restricted stock unit represents a contingent right to receive one share of Isis common stock, or its equivalent cash value. Grant of 1/30/2013 to reporting person of Restricted Stock Units under the Isis Pharmaceuticals, Inc., 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2014. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2017. The RSU is vested as to 0 shares on January 30, 2013. Grant of 1/30/2013 to reporting person of stock options under the Isis Pharamceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 1/2/2014. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 8,500 shares per year. The option is exercisable as to 0 shares on 1/30/2013. /s/C. Frank Bennett 2013-02-01